Vyant Bio, Inc. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Vyant Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q4 2022.
Vyant Bio, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$3.5M, a 13.9% increase year-over-year.
Vyant Bio, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$15.9M, a 1.31% decline year-over-year.
Vyant Bio, Inc. annual Operating Income (Loss) for 2022 was -$15.9M, a 1.31% decline from 2021.
Vyant Bio, Inc. annual Operating Income (Loss) for 2021 was -$15.7M, a 106% decline from 2020.
Vyant Bio, Inc. annual Operating Income (Loss) for 2020 was -$7.62M, a 33.7% decline from 2019.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2022	-$15.9M	-$3.5M	+$565K	+13.9%	Oct 1, 2022	Dec 31, 2022	10-K	2023-03-31
Q3 2022	-$16.5M	-$3.68M	-$405K	-12.4%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	-$16.1M	-$4.34M	-$405K	-10.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-22
Q1 2022	-$15.7M	-$4.4M	+$39K	+0.88%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	-$15.7M	-$4.06M	-$2.27M	-126%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	-$13.4M	-$3.28M	-$506K	-18.3%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$12.9M	-$3.93M	-$2.84M	-262%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-22
Q1 2021	-$10.1M	-$4.44M	-$2.46M	-125%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	-$7.62M	-$1.79M	-$1.59M	-779%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-30
Q3 2020	-$6.03M	-$2.77M	+$872K	+23.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020	-$6.91M	-$1.09M	-$377K	-53.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020	-$6.53M	-$1.97M	-$825K	-71.9%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q4 2019	-$5.7M	-$204K	-$2.22M	-110%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-31
Q3 2019	-$3.48M	-$3.64M	-$343K	-10.4%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019	-$3.14M	-$710K	+$750K	+51.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	-$3.89M	-$1.15M	+$3.8M	+76.8%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-06-24
Q4 2018	-$7.69M	$2.02M	+$11.5M		Oct 1, 2018	Dec 31, 2018	10-K	2020-05-29
Q3 2018	-$19.2M	-$3.3M	-$111K	-3.48%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-19
Q2 2018	-$19.1M	-$1.46M	+$1.65M	+53.1%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-19
Q1 2018	-$20.8M	-$4.95M	-$2.15M	-76.6%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-20
Q4 2017	-$18.6M	-$9.52M	-$6.02M	-172%	Oct 1, 2017	Dec 31, 2017	10-K	2019-04-16
Q3 2017	-$12.6M	-$3.19M	+$855K	+21.1%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-19
Q2 2017	-$13.5M	-$3.11M	+$888K	+22.2%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017	-$14.3M	-$2.8M	+$2.38M	+46%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q4 2016	-$16.7M	-$3.5M	+$3.68M	+51.3%	Oct 1, 2016	Dec 31, 2016	10-K	2018-04-02
Q3 2016	-$20.4M	-$4.04M	+$1.59M	+28.2%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-13
Q2 2016	-$22M	-$4M	+$413K	+9.36%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-14
Q1 2016	-$22.4M	-$5.18M	-$1.03M	-24.8%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-12
Q4 2015	-$21.4M	-$7.18M	-$1.22M	-20.6%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-23
Q3 2015	-$20.2M	-$5.63M	-$725K	-14.8%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	-$19.4M	-$4.41M	-$2.88K	-0.07%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-09
Q1 2015	-$19.4M	-$4.15M	-$215K	-5.47%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-10
Q4 2014	-$19.2M	-$5.95M	-$3.21M	-117%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-10
Q3 2014	-$16M	-$4.91M	-$3.23M	-192%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-09
Q2 2014	-$12.8M	-$4.41M	-$2.68M	-154%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-10
Q1 2014	-$10.1M	-$3.94M	-$1.63M	-70.5%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-11
Q4 2013	-$8.46M	-$2.74M	-$830K	-43.5%	Oct 1, 2013	Dec 31, 2013	10-K	2016-03-10
Q3 2013	-$7.63M	-$1.68M	+$30K	+1.75%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-13
Q2 2013	-$7.66M	-$1.73M	+$500K	+22.4%	Apr 1, 2013	Jun 30, 2013	10-Q/A	2014-09-23
Q1 2013	-$8.16M	-$2.31M	-$522K	-29.2%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-15
Q4 2012	-$7.64M	-$1.91M			Oct 1, 2012	Dec 31, 2012	10-K	2015-03-16
Q3 2012		-$1.71M			Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-13
Q2 2012		-$2.23M			Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-05
Q1 2012		-$1.79M			Jan 1, 2012	Mar 31, 2012	10-Q/A	2013-06-04

* An asterisk sign (*) next to the value indicates that the value is likely invalid.